In an interview with a Wausau television news station, Sterling Johnson, Phd, described how a recent renewal grant from National Institutes of Health (NIH) supports avenues for more strides in research. The funding provides $35 …
Dr. Mora Pinzon spoke to Telemundo Wisconsin about the of Alzheimer’s disease treatment ‘Leqembi’ (lecanemab) on July 14, 2023. The medication was fully approved by the U.S. Food and Drug Administration (FDA) approved on July 6, 2023.
The new funding will also enable expansion of the project to identify other causes of cognitive decline and enhance the diversity of the cohort through recruitment of people from communities historically under-represented in research.
On June 8, 2023, Wisconsin Governor Tony Evers and First Lady Kathy Evers welcomed people living with dementia and their caregivers, to dementia friendly events at the Governor’s Executive Residence.
Photos from the 2023 Breaking the Silence community event.
On behalf of the Initiative to End Alzheimer’s, we are pleased to announce the IEA Innovation Fund, providing project support for researchers at Wisconsin Alzheimer’s Institute and Wisconsin Alzheimer’s Disease Research Center. The fund was …
Dr. Mora Pinzon’s work focuses on health services research in dementia care, and improving access to dementia care for Latinx individuals.
On a recent episode of the Dementia Matters podcast, host Nathaniel Chin, MD, gives an overview of the new Alzheimer’s treatment Leqembi (lecanemab), and highlights results from the second and third phases of its clinical trials.
How sweet the sound at a live, in person concert on December 17.
20th Annual Update in Alzheimer’s Disease and Related Dementias